Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Surfactant protein B (SP-B) is a hydrophobic, pulmonary-associated protein crucial for lung function and homeostasis following birth. Encoded by the SFTPB gene, SP-B is one of the four main surfactant proteins in the lung surfactant complex, which lines the alveoli and prevents lung collapse by regulating surface tension at the air-liquid interface. Without SP-B, alveoli stick together and collapse after exhalation, causing impaired gas exchange and severe respiratory distress. Complete SP-B deficiency, caused by mutations in the SFTPB gene, is a rare, autosomal recessive disorder that presents as lethal neonatal respiratory distress syndrome. SP-B also plays a role in lamellar body formation in lung cells and the normal processing of surfactant protein C (SP-C).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Surfactant protein B (SP-B).